Carregant...
Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas
Previous studies suggest that hyperprolactinaemia might have adverse effects on lipid and glucose metabolism. We therefore aimed to evaluate whether dopamine agonist treatment with cabergoline has significant effects on blood lipids, fasting glucose and HbA1c levels in patients with micro- or macrop...
Guardat en:
| Publicat a: | Metab Brain Dis |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5566581/ https://ncbi.nlm.nih.gov/pubmed/27525431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-016-9882-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|